- An understanding of drug discovery and development processes
- Experience with programming in Python
- Familiarity with machine learning concepts
Audience
- Pharmaceutical scientists
- AI specialists
- Biotech researchers
AI-driven drug discovery is transforming the pharmaceutical industry by accelerating the identification and development of new drugs. TensorFlow is a powerful machine learning framework widely used in drug discovery. Python is the programming language of choice for implementing AI models in this field.
This instructor-led, live training (online or onsite) is aimed at advanced-level professionals who wish to leverage AI techniques to revolutionize drug discovery and development processes.
By the end of this training, participants will be able to:
- Understand the role of AI in drug discovery and development.
- Apply machine learning techniques to predict molecular properties and interactions.
- Use deep learning models for virtual screening and lead optimization.
- Integrate AI-driven approaches into the clinical trial process.
Format of the Course
- Interactive lecture and discussion.
- Lots of exercises and practice.
- Hands-on implementation in a live-lab environment.
Course Customization Options
- To request a customized training for this course, please contact us to arrange.
Introduction to AI in Drug Discovery
- Overview of traditional drug discovery processes
- The role of AI in revolutionizing drug discovery
- Case studies: Successful AI-driven drug discovery projects
Machine Learning in Molecular Modeling
- Basics of molecular modeling and simulations
- Applying machine learning to predict molecular properties
- Building predictive models for drug-target interactions
Deep Learning for Virtual Screening
- Introduction to deep learning techniques in drug discovery
- Implementing deep neural networks for virtual screening
- Case studies: AI-driven virtual screening in pharmaceutical companies
AI for Lead Optimization and Drug Design
- Techniques for optimizing lead compounds
- Using AI to predict ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) properties
- Integrating AI into the drug design pipeline
AI in Clinical Trials
- The role of AI in clinical trial design and management
- Predicting patient responses and adverse effects using AI models
- Case studies: AI applications in clinical trials
Ethical Considerations and Challenges in AI-Driven Drug Discovery
- Ethical issues in AI applications for drug discovery
- Challenges in data privacy, bias, and model interpretability
- Strategies for addressing ethical and regulatory concerns
Summary and Next Steps
United Arab Emirates - AI-Driven Drug Discovery and Development
Qatar - AI-Driven Drug Discovery and Development
Egypt - AI-Driven Drug Discovery and Development
Saudi Arabia - AI-Driven Drug Discovery and Development
South Africa - AI-Driven Drug Discovery and Development
Brasil - AI-Driven Drug Discovery and Development
Canada - AI-Driven Drug Discovery and Development
中国 - AI-Driven Drug Discovery and Development
香港 - AI-Driven Drug Discovery and Development
澳門 - AI-Driven Drug Discovery and Development
台灣 - AI-Driven Drug Discovery and Development
USA - AI-Driven Drug Discovery and Development
Österreich - AI-Driven Drug Discovery and Development
Schweiz - AI-Driven Drug Discovery and Development
Deutschland - AI-Driven Drug Discovery and Development
Czech Republic - AI-Driven Drug Discovery and Development
Denmark - AI-Driven Drug Discovery and Development
Estonia - AI-Driven Drug Discovery and Development
Finland - AI-Driven Drug Discovery and Development
Greece - AI-Driven Drug Discovery and Development
Magyarország - AI-Driven Drug Discovery and Development
Ireland - AI-Driven Drug Discovery and Development
Luxembourg - AI-Driven Drug Discovery and Development
Latvia - AI-Driven Drug Discovery and Development
España - AI-Driven Drug Discovery and Development
Italia - AI-Driven Drug Discovery and Development
Lithuania - AI-Driven Drug Discovery and Development
Nederland - AI-Driven Drug Discovery and Development
Norway - AI-Driven Drug Discovery and Development
Portugal - AI-Driven Drug Discovery and Development
România - AI-Driven Drug Discovery and Development
Sverige - AI-Driven Drug Discovery and Development
Türkiye - AI-Driven Drug Discovery and Development
Malta - AI-Driven Drug Discovery and Development
Belgique - AI-Driven Drug Discovery and Development
France - AI-Driven Drug Discovery and Development
日本 - AI-Driven Drug Discovery and Development
Australia - AI-Driven Drug Discovery and Development
Malaysia - AI-Driven Drug Discovery and Development
New Zealand - AI-Driven Drug Discovery and Development
Philippines - AI-Driven Drug Discovery and Development
Singapore - AI-Driven Drug Discovery and Development
Thailand - AI-Driven Drug Discovery and Development
Vietnam - AI-Driven Drug Discovery and Development
India - AI-Driven Drug Discovery and Development
Argentina - AI-Driven Drug Discovery and Development
Chile - AI-Driven Drug Discovery and Development
Costa Rica - AI-Driven Drug Discovery and Development
Ecuador - AI-Driven Drug Discovery and Development
Guatemala - AI-Driven Drug Discovery and Development
Colombia - AI-Driven Drug Discovery and Development
México - AI-Driven Drug Discovery and Development
Panama - AI-Driven Drug Discovery and Development
Peru - AI-Driven Drug Discovery and Development
Uruguay - AI-Driven Drug Discovery and Development
Venezuela - AI-Driven Drug Discovery and Development
Polska - AI-Driven Drug Discovery and Development
United Kingdom - AI-Driven Drug Discovery and Development
South Korea - AI-Driven Drug Discovery and Development
Pakistan - AI-Driven Drug Discovery and Development
Sri Lanka - AI-Driven Drug Discovery and Development
Bulgaria - AI-Driven Drug Discovery and Development
Bolivia - AI-Driven Drug Discovery and Development
Indonesia - AI-Driven Drug Discovery and Development
Kazakhstan - AI-Driven Drug Discovery and Development
Moldova - AI-Driven Drug Discovery and Development
Morocco - AI-Driven Drug Discovery and Development
Tunisia - AI-Driven Drug Discovery and Development
Kuwait - AI-Driven Drug Discovery and Development
Oman - AI-Driven Drug Discovery and Development
Slovakia - AI-Driven Drug Discovery and Development
Kenya - AI-Driven Drug Discovery and Development
Nigeria - AI-Driven Drug Discovery and Development
Botswana - AI-Driven Drug Discovery and Development
Slovenia - AI-Driven Drug Discovery and Development
Croatia - AI-Driven Drug Discovery and Development
Serbia - AI-Driven Drug Discovery and Development
Bhutan - AI-Driven Drug Discovery and Development